Abstract:Dysfunctional tau accumulation is a major contributing factor in tauopathies, and the heat-shock protein 70 (Hsp70) seems to play an important role in this accumulation. Several reports suggest that Hsp70 proteins can cause tau degradation to be accelerated or slowed, but how these opposing activities are controlled is unclear. Here we demonstrate that highly homologous variants in the Hsp70 family can have opposing effects on tau clearance kinetics. When overexpressed in a tetracycline (Tet)-based protein chase model, constitutive heat shock cognate 70 (Hsc70) and inducible Hsp72 slowed or accelerated tau clearance, respectively. Tau synergized with Hsc70, but not Hsp72, to promote microtubule assembly at nearly twice the rate of either Hsp70 homologue in reconstituted, ATP-regenerating Xenopus extracts supplemented with rhodamine-labeled tubulin and human recombinant Hsp72 and Hsc70. Nuclear magnetic resonance spectroscopy with human recombinant protein revealed that Hsp72 had greater affinity for tau than Hsc70 (I/I0 ratio difference of 0.3), but Hsc70 was 30 times more abundant than Hsp72 in human and mouse brain tissue. This indicates that the predominant Hsp70 variant in the brain is Hsc70, suggesting that the brain environment primarily supports slower tau clearance. Despite its capacity to clear tau, Hsp72 was not induced in the Alzheimer's disease brain, suggesting a mechanism for age-associated onset of the disease. Through the use of chimeras that blended the domains of Hsp72 and Hsc70, we determined that the reason for these differences between Hsc70 and Hsp72 with regard to tau clearance kinetics lies within their C-terminal domains, which are essential for their interactions with substrates and cochaperones. Hsp72 but not Hsc70 in the presence of tau was able to recruit the cochaperone ubiquitin ligase CHIP, which is known to facilitate the ubiquitination of tau, describing a possible mechanism of how the C-termini of these homologous Hsp70 variants can differentially regulate tau triage. Thus, efforts to promote Hsp72 expression and inhibit Hsc70 could be therapeutically relevant for tauopathies.

Hsp90-Tau complex reveals molecular basis for specificity in chaperone action

Molecular-level interplay between intrinsically disordered clients and Hsp90

Structural basis for recognition of the Hsp90 closed, ATP state by the TPR‐containing co‐chaperone FKBP51

Folding or holding?-Hsp70 and Hsp90 chaperoning of misfolded proteins in neurodegenerative disease

Structural basis for the dynamic chaperoning of disordered clients by Hsp90

Imbalance of Hsp70 family variants fosters tau accumulation

HspB1 and Hsc70 chaperones engage distinct tau species and have different inhibitory effects on amyloid formation.

Site‐selectively Phosphorylated Hsp90 C‐terminal Domain Variants Provide Access to Deciphering the Chaperone Code.

Folding and Domain Interactions of Three Orthologs of Hsp90 Studied by Single-Molecule Force Spectroscopy

Hsp90 chaperones protein folding in vitro

Hsp90 Chaperone Activity Requires the Full-length Protein and Interaction among Its Multiple Domains

Synthetic chaperone based on Hsp90-Tau interaction inhibits pathological Tau aggregation and rescues physiological Tau-Microtubule interaction

Structural Basis of Client Specificity in Mitochondrial Membrane-Protein Chaperones

The structure of an Hsp90-immunophilin complex reveals cochaperone recognition of the client maturation state

Hsp90 structure and function studied by NMR spectroscopy

Structure of an Hsp90-immunophilin complex reveals cochaperone recognition of the client-maturation state

HSP90 at the hub of protein homeostasis: emerging mechanistic insights

The Hsp70–Hsp90 Chaperone Cascade in Protein Folding

Establishing Order through Disorder by the Hsp90 Molecular Chaperone

Capturing the Conformational Heterogeneity of HSPB1 Chaperone Oligomers at Atomic Resolution

Spatially and kinetically resolved changes in the conformational dynamics of the Hsp90 chaperone machine